Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Editorial: Advancements in Biomarkers and Their Role in Forecasting and Personalizing Treatment for Inflammatory Bowel Diseases

  • By

  • Arianna Dal Buono

  • Olga Maria Nardone

  • Rocio Ferreiro-Iglesias

  • June 17, 2026

Share

Original Source(s)

Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases

  • by Arianna Dal Buono, Olga Maria Nardone, Rocio Ferreiro-Iglesias

  • June 17, 2026

Related Content

Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease

Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study